Home > News > Targeting Nanoparticles to Pancreatic Cancer In Vivo
November 9th, 2005
Targeting Nanoparticles to Pancreatic Cancer In Vivo
Abstract:
Taking a page from pharmaceutical chemists, researchers at the Massachusetts General Hospital and the Harvard Medical School have created a library of 146 different nanoparticles that they were then able to search for nanoparticles capable of targeting specific cells in the body. Using this approach, the investigators have found a previously undiscovered nanoparticle capable of targeting pancreatic cancer in vivo.
Source:
nano.cancer.gov
Related Links |
Massachusetts General Hospital
Related News Press |
Possible Futures
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Materials/Metamaterials/Magnetoresistance
Chainmail-like material could be the future of armor: First 2D mechanically interlocked polymer exhibits exceptional flexibility and strength January 17th, 2025
Enhancing transverse thermoelectric conversion performance in magnetic materials with tilted structural design: A new approach to developing practical thermoelectric technologies December 13th, 2024
FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |